Biomedical subjects

C A Castro

Publications and source records attributed to C A Castro.

23 records · Page 2Linked to original sources

PubMed1989

Early-life malnutrition impairs the performance of both young and adult rats on visual discrimination learning tasks.

Previously malnourished young (20-40-day-old) and mature (70-77-day-old) rats were compared on position, brightness, and pattern discrimination problems using an aquatic version of the Lashley jump stand. Malnutrition did not affect performance on the position discrimination. In contrast, previously malnourished 24-34-day-olds failed to solve the brightness discrimination, 40-day-olds were impaired on the brightness problem, and 40-77-day olds were impaired on the pattern problem. The impaired performance of the 40-day-olds on the brightness problem was eliminated by prior training on the pattern discriminations, and the impaired performance of the 70-day-olds on the pattern discrimination could be eliminated if they were first trained on the brightness problem. These impairments were attributed to the effects of early-life malnutrition on the maturation of attention processes that enable the rat to suppress responding to irrelevant cues. The relevance of a contextual-organismic perspective for understanding the effects of early-life malnutrition was discussed.

Age Factors↗

PubMed1989

Pleuropulmonary actinomycosis associated with a systemic-to-pulmonary artery fistula and contralateral metastatic back mass.

We report a case of systemic-to-pulmonary artery fistula associated with thoracic actinomycosis and with metastatic hematogenous dissemination to the soft tissues of the back. The difficulty in diagnosing thoracic actinomycosis may predispose to the increased incidence of hematogenous spread of this disease. Although resection of pulmonary tissue including the infectious mass was required in previous cases, resection of the pleural mass alone was curative in this patient when combined with penicillin therapy.

Abscess↗

PubMed1987

Early-life malnutrition selectively retards the development of distal- but not proximal-cue navigation.

The effects of early-life malnutrition on the distal-cue and proximal-cue versions of the Morris (1981) water maze were studied with different-aged rats. Consistent with the existing literature, malnutrition only mildly influenced the distal-cue navigation of relatively old pups (30 day olds). Pups 20-27 days old, however, displayed no evidence of distal-cue navigation if they had been malnourished previously. Malnutrition had no effect on proximal-cue based navigation by pups at any age. The effect of malnutrition on distal-cue performance could not be attributed to any general debilitating effects, sensory, motor, or motivational deficits. Instead, it appears to selectively influence the development of the neural system (perhaps the hippocampus and related structures) more directly involved in learning to utilize distal cues.

Aging↗

PubMedDate not supplied

Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327.

The effect of combining a radiation-protective phosphorothioate with another agent was investigated in an attempt to increase radioprotection and reduce toxicity. The calcium channel blocker nimodipine (NIMO) was administered alone (1 or 10 mg kg-1) or in combination with 200 mg kg-1 of the phosphorothioate radioprotector WR-151327 (WR) (S-3-(3-methylaminopropylamino)propylphosphorothioic acid). Radioprotection as measured (30-day survival) of mice treated i.p. 30 min before (60)Co irradiation at a dose rate of 1 Gy min-1 was evaluated in CD2F1 male mice. The effects of nimodipine and WR-151327 on locomotor activity were investigated also in a separate group of non-irradiated mice. The LD(50/30) for the Emulphor vehicle control group was 8.56. For nimodipine alone (1 or 10 mg kg-1) the LD(50/30)was 8.39 and 10.21 Gy, respectively, yielding dose modification factors (DMFs) of 0.98 and 1.19, respectively. When WR-151327 was given alone, the <LD(50/30) was 12.48 Gy (DMF = 1.46; P < 0.05 from vehicle). WR-151327 combined with 1 or 10 mg kg-1 nimodipine resulted in an LD(50/30) of 12.73 Gy (DMF 1.49, P < 0.05 from vehicle), and when WR-151327 was combined with 10 mg kg-1 nimodipine the LD(50/30) was 14.29 Gy (DMF = 1.67, P < 0.001 from WR-151327). For either dose of nimodipine, locomotor activity did not differ from vehicle. WR-151327 and WR-151327 + 1 mg kg-1 nimodipine resulted in locomotor decrements for up to 4 h post-administration (P < 0.05 from vehicle), and WR-151327 + 10 mg kg-1 nimodipine for up to 6 h (P < 0.05 from WR-151327). Therefore, although there was an additive radioprotective effect when the higher dose of nimodipine was combined with WR-151327, the locomotor decrement was also enhanced. These results demonstrate that a combination of nimodipine and a phosphorothioate such as WR-151327 may be useful as a clinical setting where behavioral and physiological side-effects can be monitored. Published in 2001 by John Wiley & Sons, Ltd.

Animals↗

PubMedDate not supplied

Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase.

Recently, it has been demonstrated that an exogenously administered enzyme such as butyrylcholinesterase (BuChE) can prevent death in rhesus monkeys exposed to multiple-lethal doses of the acetylcholinesterase inhibitor soman when the enzyme is given prior to soman exposure (3). We report that despite BuChE protecting against soman-induced lethality, behavioral effects are seen in these monkeys which last for at least 6 days as measured by performance on a serial probe recognition (SPR) task. Analyses of the serial position curves showed that performance was lower on the probe trials when the probe items were from the middle of the list than when the probe items were from the beginning or end of the list which were unaffected. BuChE given alone also produced behavioral effects, causing all animals not to respond on the probe trials until 8 h following BuChE administration. Taken together, these findings suggest that the BuChE is not completely binding all of the soman and that a concentration of soman which is capable of causing behavioral effects may be entering the CNS.

Animals↗